Structure via PubChem · Public domain (PubChem)
Chemical data
- Formula
- C19H20Br2N6O4S
- Molecular weight
- 588.3 g/mol
- IUPAC name
- 5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine
- SMILES
- CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br
- InChIKey
- JGCMEBMXRHSZKX-UHFFFAOYSA-N
- XLogP
- 3.7
- Polar surface area
- 137 Ų
- H-bond donors
- 2
- H-bond acceptors
- 10
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 2010
- Admin. routes
- oral
- Indications
- pulmonary arterial hypertension, idiopathic pulmonary fibrosis, systemic scleroderma, glioblastoma multiforme
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 585.9633483200003
- Has use
- medication
Show 7 more facts
- chemical formula
- C₁₉H₂₀Br₂N₆O₄S
- canonical SMILES
- CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br
- World Health Organisation international non-proprietary name
- macitentan
- defined daily dose
- 10
- medical condition treated
- pulmonary hypertension
- Commons category
- Macitentan
- legal status (medicine)
- boxed warning
Sources (7)
via Wikidata · CC0
Article · Deutsch
Macitentan (Handelsname Opsumit; Hersteller Actelion Pharmaceuticals Ltd) ist ein Arzneistoff aus der Gruppe der dualen Endothelin-Rezeptor-Antagonisten (ERA). Er wird in der Behandlung eines erhöhten Blutdrucks im Lungenkreislauf (pulmonale arterielle Hypertonie) eingesetzt.
Abstract from DBpedia / Wikipedia · CC BY-SA
Gallery (2)
Available in 11 languages
via Wikidata sitelinks · CC0